Coal India, Lupin, Aurobindo Pharma, Wockhardt, RCom hit 52-week low
Videocon is also locked lower circuit for second straight day, down 20% on back of heavy volumes
 "Coal India, Lupin, Aurobindo Pharma, Wockhardt, RCom hit 52-week low")
premium
Shares of pharmaceutical companies were under pressure with as many as seven stocks from the BSE500 index such as Lupin, Aurobindo Pharma, Divi’s Laboratories, Glenmark Pharmaceuticals, Indoco Remedies, Strides Shasun and Wockhardt hit their respective 52-week lows on the BSE in intra-day trade.
Besides these seven stocks, Coal India, Inox Wind, KPIT Technologies, Majesco, Reliance Communications (RCom), TV Today Network and Videocon Industries, total 14 stocks from the index trading at their 52-week lows on BSE.
Videocon Industries is locked lower circuit for the second straight day, down 20% at Rs 64.80 on back of heavy volumes. Till 09:58 am; a combined 184,086 shares have changed hands on the BSE and NSE. There were pending sell orders for 8.58 million shares on both the exchanges.
Videocon Industries, almost the entire promoters’ holding in the company—about 99.26%—was pledged, which has been the case for the past five quarters, the shareholding pattern data shows.
RCom hit a record low of Rs 27.25, down 8.6% on BSE in intra-day trade. The Credit Analysis & Research Limited (CARE) on May 19, had revised the long term facility rating from ‘CARE A-‘ to ‘CARE BB' and the short term facility rating from ‘CARE A2+ to ‘CARE A4', with credit watch with developing implications.
“CARE stated that the revision in the rating factors change in the competitive landscape of the telecom industry with the entry of the new operator, intense competition putting pressure on the sector profitability, and delay in the deleveraging exercise of the Company,” RCom said in a regulatory filing.
Aurobindo Pharma slipped 6.4% to Rs 539, extending it’s a month long fall, after the company’s formulations manufacturing facility at Bachupally in Hyderabad had received Form 483 with six observations.
The US Food and Drug Administration (FDA) had issued the observation letter after conducting an inspection at unit-III during April 10-18, 2017.
"At the end of the inspection, we have been issued a Form 483 with 6 observations. The observations are all on procedural improvements. None of them are related to data integrity. The company will be responding as per the prescribed time lines," Aurobindo Pharma on April 19, said in BSE filing.
Meanwhile, the S&P BSE Healthcare index has dipped nearly 3% or 429 points to 14,184 after a sharp fall in pharmaceutical stocks.
Besides these seven stocks, Coal India, Inox Wind, KPIT Technologies, Majesco, Reliance Communications (RCom), TV Today Network and Videocon Industries, total 14 stocks from the index trading at their 52-week lows on BSE.
Videocon Industries is locked lower circuit for the second straight day, down 20% at Rs 64.80 on back of heavy volumes. Till 09:58 am; a combined 184,086 shares have changed hands on the BSE and NSE. There were pending sell orders for 8.58 million shares on both the exchanges.
Videocon Industries, almost the entire promoters’ holding in the company—about 99.26%—was pledged, which has been the case for the past five quarters, the shareholding pattern data shows.
RCom hit a record low of Rs 27.25, down 8.6% on BSE in intra-day trade. The Credit Analysis & Research Limited (CARE) on May 19, had revised the long term facility rating from ‘CARE A-‘ to ‘CARE BB' and the short term facility rating from ‘CARE A2+ to ‘CARE A4', with credit watch with developing implications.
“CARE stated that the revision in the rating factors change in the competitive landscape of the telecom industry with the entry of the new operator, intense competition putting pressure on the sector profitability, and delay in the deleveraging exercise of the Company,” RCom said in a regulatory filing.
Aurobindo Pharma slipped 6.4% to Rs 539, extending it’s a month long fall, after the company’s formulations manufacturing facility at Bachupally in Hyderabad had received Form 483 with six observations.
The US Food and Drug Administration (FDA) had issued the observation letter after conducting an inspection at unit-III during April 10-18, 2017.
"At the end of the inspection, we have been issued a Form 483 with 6 observations. The observations are all on procedural improvements. None of them are related to data integrity. The company will be responding as per the prescribed time lines," Aurobindo Pharma on April 19, said in BSE filing.
Meanwhile, the S&P BSE Healthcare index has dipped nearly 3% or 429 points to 14,184 after a sharp fall in pharmaceutical stocks.
| COMPANY | LATEST | 52 WK LOW | PREV LOW | PREV DATE |
| AUROBINDO PHARMA | 546.00 | 544.00 | 575.00 | 22-May-17 |
| COAL INDIA | 270.65 | 270.15 | 273.70 | 27-Apr-17 |
| DIVI'S LAB. | 575.00 | 573.00 | 592.00 | 22-May-17 |
| GLENMARK PHARMA. | 651.45 | 649.00 | 653.50 | 22-May-17 |
| INDOCO REMEDIES | 197.05 | 196.50 | 201.00 | 22-May-17 |
| INOX WIND | 143.45 | 142.45 | 150.45 | 22-May-17 |
| KPIT TECH. | 115.65 | 115.40 | 121.30 | 22-Nov-16 |
| LUPIN | 1245.00 | 1242.00 | 1242.50 | 09-May-17 |
| MAJESCO | 324.65 | 324.00 | 330.15 | 31-Mar-17 |
| REL. COMM. | 27.80 | 27.25 | 29.70 | 22-May-17 |
| STRIDES SHASUN | 897.00 | 894.60 | 918.00 | 29-Aug-16 |
| T.V. TODAY NETW. | 249.00 | 249.00 | 250.00 | 20-Dec-16 |
| VIDEOCON INDS. | 64.80 | 64.80 | 80.40 | 22-May-17 |
| WOCKHARDT | 619.00 | 616.60 | 627.00 | 27-Dec-16 |
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%